|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global Lnds - an update. Cancer Epidemiol Biomarkers Prev.
25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farooqi AA, Legaki E, Gazouli M, Rinaldi S
and Berardi R: Withdrawal Notice: MALAT1 as a versatile regulator
of cancer: overview of the updates from predatory role as
competitive endogenous RNA to mechanistic in-sights. Curr Cancer
Drug Targets. Jul 30–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Zhang Q, Hu Y, Zhu J and Yang J:
Emerging role of long non-coding RNA MALAT1 in predicting clinical
outcomes of patients with digestive system malignancies: A
meta-analysis. Oncol Lett. 17:2159–2170. 2019.PubMed/NCBI
|
|
4
|
Dai Q, Zhang T and Li C: LncRNA MALAT1
regulates the cell proliferation and cisplatin resistance in
gastric cancer via PI3K/AKT pathway. Cancer Manag Res.
12:1929–1939. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shao G, Zhao Z, Zhao W, Hu G, Zhang L, Li
W, Xing C and Zhang X: Long non-coding RNA MALAT1 activates
autophagy and promotes cell proliferation by downregulating
microRNA-204 expression in gastric cancer. Oncol Lett. 19:805–812.
2020.PubMed/NCBI
|
|
6
|
Yao W, Bai Y, Li Y, Guo L, Zeng P, Wang Y,
Qi B, Liu S, Qin X, Li Y, et al: Upregulation of MALAT-1 and its
association with survival rate and the effect on cell cycle and
migration in patients with esophageal squamous cell carcinoma.
Tumour Biol. 37:4305–4312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li RQ, Ren Y, Liu W, Pan W, Xu FJ and Yang
M: MicroRNA-mediated silence of onco-lncRNA MALAT1 in different
ESCC cells via ligand-functionalized hydroxyl-rich nanovectors.
Nanoscale. 9:2521–2530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen M, Xia Z, Chen C, Hu W and Yuan Y:
LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of
esophageal cancer through Ezh2-Notch1 signaling pathway. Anticancer
Drugs. 29:767–773. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang QQ, Cui YH, Wang Y, Kou WZ, Cao F,
Cao XJ, Miao ZH and Kang XH: Mechanism of long non-coding
RNA-metastasis associated lung adenocarcinoma transcript 1 induced
invasion and metastasis of esophageal cancer cell EC-109. Zhonghua
Zhong Liu Za Zhi. 39:405–411. 2017.(In Chinese). PubMed/NCBI
|
|
12
|
Wang W, Zhu Y, Li S, Chen X, Jiang G, Shen
Z, Qiao Y, Wang L, Zheng P and Zhang Y: Long noncoding RNA MALAT1
promotes malignant development of esophageal squamous cell
carcinoma by targeting β-catenin via Ezh2. Oncotarget.
7:25668–25682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao Q, Yang J, Liu T, Zhang J and Zheng Y:
Long noncoding RNA MALAT1 promotes the stemness of esophageal
squamous cell carcinoma by enhancing YAP transcriptional activity.
FEBS Open Bio. 9:1392–1402. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu Y, Shao N, Yang W, Wang J and Cheng Y:
Association of polymorphisms in MALAT1 with the risk of esophageal
squamous cell carcinoma in a Chinese population. Onco Targets Ther.
12:2495–2503. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang K, Huang YH, Li HP and Guo SM:
Expression of UCA1 and MALAT1 long-chain non-coding RNAs in
esophageal squamous cell carcinoma tissues is predictive of patient
prognosis. Arch Med Sci. 14:752–759. 2018.PubMed/NCBI
|
|
16
|
Huang C, Yu Z, Yang H and Lin Y: Increased
MALAT1 expression predicts poor prognosis in esophageal cancer
patients. Biomed Pharmacother. 83:8–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Zhou Y, Tu B, Bu Y, Liu A and Kong
J: Long noncoding RNA MALAT1 affects the efficacy of radiotherapy
for esophageal squamous cell carcinoma by regulating Cks1
expression. J Oral Pathol Med. 46:583–590. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Chen Z, Li MJ, Guo HY and Jing
NC: Long non-coding RNA metastasis-associated lung adenocarcinoma
transcript 1 regulates the expression of Gli2 by miR-202 to
strengthen gastric cancer progression. Biomed Pharmacother.
85:264–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Gao J, Tian W, Li Y and Zhang J:
Long non-coding RNA MALAT1 drives gastric cancer progression by
regulating HMGB2 modulating the miR-1297. Cancer Cell Int.
17:442017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Zhao J, Zhang H and Cai J: Silencing
of lncRNA metastasis-associated lung adenocarcinoma transcript 1
inhibits the proliferation and promotes the apoptosis of gastric
cancer cells through regulating microRNA-22-3p-mediated ErbB3. Onco
Targets Ther. 13:559–571. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Li M and Zhang Z: lncRNA MALAT1
modulates oxaliplatin resistance of gastric cancer via sponging
miR-22-3p. Onco Targets Ther. 13:1343–1354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan L, Zhang J, Guo D, Ma J, Shui SF and
Han XW: IL-21R functions as an oncogenic factor and is regulated by
the lncRNA MALAT1/miR-125a-3p axis in gastric cancer. Int J Oncol.
54:7–16. 2019.PubMed/NCBI
|
|
26
|
Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H,
Fang G and Xue X: MALAT1 promotes gastric adenocarcinoma through
the MALAT1/miR-181a-5p/AKT3 axis. Open Biol. 9:1900952019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu K, Ren Q and Zhao Y: lncRNA MALAT1
overexpression promotes proliferation, migration and invasion of
gastric cancer by activating the PI3K/AKT pathway. Oncol Lett.
17:5335–5342. 2019.PubMed/NCBI
|
|
28
|
Li H, He C, Wang X, Wang H, Nan G and Fang
L: MicroRNA-183 affects the development of gastric cancer by
regulating autophagy via MALAT1-miR-183-SIRT1 axis and
PI3K/AKT/mTOR signals. Artif Cells Nanomed Biotechnol.
47:3163–3171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu YR, Yu YC, You S, Li K, Tong X, Chen S,
Chen E, Lin XZ and Chen Y: Long noncoding RNA MALAT1 regulates
autophagy associated chemoresistance via miR-23b-3p sequestration
in gastric cancer. Mol Cancer. 16:1742017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xi Z, Si J and Nan J: LncRNA MALAT1
potentiates autophagy-associated cisplatin resistance by regulating
the microRNA-30b/autophagy-related gene 5 axis in gastric cancer.
Int J Oncol. 54:239–248. 2019.PubMed/NCBI
|
|
31
|
Zhang YF, Li CS, Zhou Y and Lu XH:
Propofol facilitates cisplatin sensitivity via lncRNA
MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric
cancer. Life Sci. 244:1172802020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li L, Geng Y, Feng R, Zhu Q, Miao B, Cao J
and Fei S: The human RNA surveillance factor UPF1 modulates gastric
cancer progression by targeting long non-coding RNA MALAT1. Cell
Physiol Biochem. 42:2194–2206. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng QJ, Xie LQ and Li H: Overexpressed
MALAT1 promotes invasion and metastasis of gastric cancer cells via
increasing EGFL7 expression. Life Sci. 157:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee NK, Lee JH, Ivan C, Ling H, Zhang X,
Park CH, Calin GA and Lee SK: MALAT1 promoted invasiveness of
gastric adenocarcinoma. BMC Cancer. 17:462017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen D, Liu L, Wang K, Yu H, Wang Y, Liu
J, Guo Y and Zhang H: The role of MALAT-1 in the invasion and
metastasis of gastric cancer. Scand J Gastroenterol. 52:790–796.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Z, Xie Q, Chen Z, Ni H, Xia L, Zhao
Q, Chen Z and Chen P: Resveratrol suppresses the invasion and
migration of human gastric cancer cells via inhibition of
MALAT1-mediated epithelial-to-mesenchymal transition. Exp Ther Med.
17:1569–1578. 2019.PubMed/NCBI
|
|
38
|
Xiao Y, Pan J, Geng Q and Wang G: LncRNA
MALAT1 increases the stemness of gastric cancer cells via enhancing
SOX2 mRNA stability. FEBS Open Bio. 9:1212–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, et
al: Metastasis-associated long non-coding RNA drives gastric cancer
development and promotes peritoneal metastasis. Carcinogenesis.
35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
